EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Impella 5.5 Support in Severe Cardiogenic Shock: Outcomes From the First Spanish Multicentre Cohort in Heart Transplant Centres

José Manuel Martínez-Comendador iD, Elio Martín Gutiérrez, Daniel Ortiz Berbel, Lucía García Alcalde, Álvaro Pedraz Prieto, Christian Muñoz-Guijosa, Carlos Esteban Martín López, Stefano Urso iD, Gregorio Rábago Juan Aracil, José Joaquín Cuenca Castillo, Manuel Pérez-Guillén

Interdisciplinary CardioVascular and Thoracic Surgery · 05.05.2026 · 41 (5)

DOI: 10.1093/icvts/ivag137 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, online erschienen am 13.05.2026. Verfasst von José Manuel Martínez-Comendador und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, A Coruña University Hospital Complex (CHUAC), A Coruña, 15006, Spain. Hauptthemen laut MEDLINE: Shock, Cardiogenic, Heart-Assist Devices, Heart Transplantation. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Impella 5.5 is an established temporary mechanical circulatory support (tMCS) device for severe cardiogenic shock. Spain, characterized by high heart transplant activity and increasing use of controlled donation after circulatory death (DCD), provides a relevant setting to evaluate its use and outcomes. We aimed to describe clinical characteristics, trajectories, and outcomes of Impella 5.5 support in the first Spanish multicentre cohort from heart transplant centres.

Methods

Retrospective multicentre observational study including consecutive patients supported with Impella 5.5 in hospitals with active heart transplant programmes. Baseline characteristics, Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) profile, additional support, complications, support duration, and in-hospital mortality were recorded. Outcomes were analysed across INTERMACS profiles.

Results

Ninety-three patients were included (33 INTERMACS 1, 37 INTERMACS 2, 23 INTERMACS 3). Additional support was required in 46%, mainly venoarterial extracorporeal life support (VA-ECLS). Device-related complications were reported as event frequencies. The predominant clinical trajectory was heart transplantation (68.8%), contrasting with international series in which long-term mechanical support and transplantation are more evenly distributed. In-hospital mortality was 43%, with a clear gradient across INTERMACS profiles 1-3 (60.6%, 37.8%, and 26.1%, respectively; P = .013). Mean support duration was 16 days, and more than one-third of transplants were from controlled DCD donors.

Conclusions

Impella 5.5 was used as tMCS in severe cardiogenic shock and was predominantly associated with heart transplantation in a transplant-oriented healthcare system. Outcomes were closely associated with INTERMACS profile, reflecting differences in baseline severity and patient selection. Comparisons with international registries are descriptive only.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shock, CardiogenicHeart-Assist DevicesHeart TransplantationHumansRetrospective StudiesFemaleSpainMaleMiddle AgedHospital MortalityTreatment OutcomeSeverity of Illness IndexAgedAdultRegistriesTime Factors

Stichwörter der Autor:innen

Impella 5.5cardiogenic shockheart transplantationtemporary mechanical circulatory supportventricular assist device

Autor:innen und Institutionen

  • Department of Cardiac Surgery, A Coruña University Hospital Complex (CHUAC), A Coruña, 15006, Spain.
  • Biomedical Research Institute of A Coruña (INIBIC), A Coruña, 15006, Spain.
  • Department of Cardiovascular Surgery, Virgen de la Arrixaca University Hospital, Murcia, 30120, Spain.
  • Murcian Institute for Biosanitary Research (IMIB Arrixaca), Murcia, 30120, Spain.
  • Department of Cardiac Surgery, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, 08907, Spain.
  • Department of Cardiac Surgery, Marqués de Valdecilla University Hospital, Santander, Cantabria, 39008, Spain.

ORCID-Profile: José Manuel Martínez-Comendador, Stefano Urso

Zitieren

APA

Martínez-Comendador, J. M., Martín Gutiérrez, E., Ortiz Berbel, D., Alcalde, L. G., Pedraz Prieto, Á., Muñoz-Guijosa, C., Martín López, C. E., Urso, S., Rábago Juan Aracil, G., Cuenca Castillo, J. J., & Pérez-Guillén, M. (2026). Impella 5.5 Support in Severe Cardiogenic Shock: Outcomes From the First Spanish Multicentre Cohort in Heart Transplant Centres. Interdisciplinary CardioVascular and Thoracic Surgery, 41(5). https://doi.org/10.1093/icvts/ivag137

Vancouver

Martínez-Comendador JM, Martín Gutiérrez E, Ortiz Berbel D, Alcalde LG, Pedraz Prieto Á, Muñoz-Guijosa C, et al. Impella 5.5 Support in Severe Cardiogenic Shock: Outcomes From the First Spanish Multicentre Cohort in Heart Transplant Centres. Interdisciplinary CardioVascular and Thoracic Surgery. 2026;41(5). doi:10.1093/icvts/ivag137

BibTeX
@article{MartnezComendador2026,
  author = {Martínez-Comendador, José Manuel and Martín Gutiérrez, Elio and Ortiz Berbel, Daniel and Alcalde, Lucía García and Pedraz Prieto, Álvaro and Muñoz-Guijosa, Christian and Martín López, Carlos Esteban and Urso, Stefano and Rábago Juan Aracil, Gregorio and Cuenca Castillo, José Joaquín and Pérez-Guillén, Manuel},
  title = {Impella 5.5 Support in Severe Cardiogenic Shock: Outcomes From the First Spanish Multicentre Cohort in Heart Transplant Centres},
  journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
  year = {2026},
  volume = {41},
  number = {5},
  doi = {10.1093/icvts/ivag137}
}
Kostenlos starten →